nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antimicrobial resistance among enteric pathogens
|
Pickering, Larry K |
|
2004 |
15 |
2 |
p. 71-77 7 p. |
artikel |
2 |
Antimicrobial resistance in countries with limited resources: unique challenges and limited alternatives
|
Sirinavin, Sayomporn |
|
2004 |
15 |
2 |
p. 94-98 5 p. |
artikel |
3 |
Antimicrobial resistance: is it really that bad?
|
Dowell, Scott F |
|
2004 |
15 |
2 |
p. 99-104 6 p. |
artikel |
4 |
Antimicrobial use in agriculture: controlling the transfer of antimicrobial resistance to humans 1 1 This article is based in part on an appendix written for an Institute of Medicine workshop summary by Anderson AD, McClellan J, Rossiter S, Angulo FJ entitled Public Health Consequences of Use of Antimicrobial Agents in Agriculture in “The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment-Workshop Summary,” Stacey L. Knobler, Stanley M. Lemon, Marian Najafi, and Tom Burroughs (Eds.), Institute of Medicine of the National Academies, Washington, DC, The National Academies Press, 231–243, 2003.
|
Angulo, Frederick J |
|
2004 |
15 |
2 |
p. 78-85 8 p. |
artikel |
5 |
Clinically silent infection in a premature infant
|
Bohn, Georg |
|
2004 |
15 |
2 |
p. 69-70 2 p. |
artikel |
6 |
Denouement
|
|
|
2004 |
15 |
2 |
p. 115-117 3 p. |
artikel |
7 |
Editorial
|
Feigin, Ralph D |
|
2004 |
15 |
2 |
p. 65-66 2 p. |
artikel |
8 |
Editorial board
|
|
|
2004 |
15 |
2 |
p. RF2- 1 p. |
artikel |
9 |
Introduction
|
Dowell, Scott F |
|
2004 |
15 |
2 |
p. 67-68 2 p. |
artikel |
10 |
Sir Howard Walter Florey—the force behind the development of penicillin
|
Lee Ligon, B |
|
2004 |
15 |
2 |
p. 109-114 6 p. |
artikel |
11 |
Table of contents
|
|
|
2004 |
15 |
2 |
p. RF3-RF4 nvt p. |
artikel |
12 |
Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine
|
Whitney, Cynthia G |
|
2004 |
15 |
2 |
p. 86-93 8 p. |
artikel |
13 |
Who defines resistance? the clinical and economic impact of antimicrobial susceptibility testing breakpoints
|
Jorgensen, James H |
|
2004 |
15 |
2 |
p. 105-108 4 p. |
artikel |